NOV Inc. (BMV:NOV)
Mexico · Delayed Price · Currency is MXN 250.00
0.00 (0.00%)
May 12, 2025, 12:35 PM CST
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 471 | 635 | 993 | 155 | -250 | -2,542 | Upgrade |
Depreciation & Amortization | 378 | 371 | 325 | 301 | 306 | 352 | Upgrade |
Loss (Gain) From Sale of Assets | 1 | -130 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 4 | 127 | - | 1,891 | Upgrade |
Loss (Gain) on Equity Investments | - | -36 | -119 | -68 | 5 | 260 | Upgrade |
Stock-Based Compensation | 67 | 70 | 66 | 67 | 78 | 105 | Upgrade |
Other Operating Activities | 57 | 179 | -542 | -2 | 112 | 331 | Upgrade |
Change in Accounts Receivable | 172 | 255 | -324 | -660 | 98 | 604 | Upgrade |
Change in Inventory | 190 | 270 | -361 | -480 | 17 | 429 | Upgrade |
Change in Accounts Payable | 12 | -87 | -4 | 289 | 118 | -226 | Upgrade |
Change in Unearned Revenue | 5 | -42 | 82 | 52 | 27 | -74 | Upgrade |
Change in Income Taxes | - | -5 | -6 | 5 | -28 | 9 | Upgrade |
Change in Other Net Operating Assets | -77 | -176 | 29 | 35 | -192 | -213 | Upgrade |
Operating Cash Flow | 1,276 | 1,304 | 143 | -179 | 291 | 926 | Upgrade |
Operating Cash Flow Growth | 65.50% | 811.89% | - | - | -68.58% | 29.69% | Upgrade |
Capital Expenditures | -367 | -351 | -283 | -214 | -201 | -226 | Upgrade |
Cash Acquisitions | -46 | -298 | -22 | -49 | -52 | -14 | Upgrade |
Divestitures | - | 176 | - | - | - | - | Upgrade |
Other Investing Activities | 6 | 2 | 12 | 25 | 57 | 96 | Upgrade |
Investing Cash Flow | -407 | -471 | -293 | -238 | -196 | -144 | Upgrade |
Long-Term Debt Issued | - | 420 | 184 | 20 | 60 | 36 | Upgrade |
Long-Term Debt Repaid | - | -459 | -215 | -28 | -209 | -248 | Upgrade |
Net Debt Issued (Repaid) | -50 | -39 | -31 | -8 | -149 | -212 | Upgrade |
Repurchase of Common Stock | -342 | -229 | - | - | - | - | Upgrade |
Common Dividends Paid | -193 | -108 | -79 | -78 | -20 | -19 | Upgrade |
Other Financing Activities | -41 | -30 | 7 | -10 | -20 | -28 | Upgrade |
Financing Cash Flow | -626 | -406 | -103 | -96 | -189 | -259 | Upgrade |
Foreign Exchange Rate Adjustments | 10 | -13 | - | -9 | -7 | -2 | Upgrade |
Net Cash Flow | 253 | 414 | -253 | -522 | -101 | 521 | Upgrade |
Free Cash Flow | 909 | 953 | -140 | -393 | 90 | 700 | Upgrade |
Free Cash Flow Growth | 93.40% | - | - | - | -87.14% | 45.53% | Upgrade |
Free Cash Flow Margin | 10.34% | 10.74% | -1.63% | -5.43% | 1.63% | 11.49% | Upgrade |
Free Cash Flow Per Share | 2.35 | 2.41 | -0.35 | -1.00 | 0.23 | 1.82 | Upgrade |
Cash Interest Paid | 83 | 86 | 85 | 75 | 76 | 83 | Upgrade |
Cash Income Tax Paid | 170 | 161 | 114 | 117 | -78 | -9 | Upgrade |
Levered Free Cash Flow | 821.75 | 1,014 | -117.25 | -240.5 | 306.13 | 893.75 | Upgrade |
Unlevered Free Cash Flow | 877.38 | 1,071 | -62.25 | -191.75 | 354.25 | 946.25 | Upgrade |
Change in Working Capital | 302 | 215 | -584 | -759 | 40 | 529 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.